Geron (GERN) Up 2.4% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/06/19
Geron Corporation (GERN) CEO John Scarlett on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/07/19
Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic SyndromesGlobeNewsWire • 10/10/19
Geron Announces Fast Track Designation Granted to Imetelstat for Relapsed/Refractory MyelofibrosisGlobeNewsWire • 09/30/19
Geron Corp (GERN) CEO John Scarlett on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/02/19